Barchart.com
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Eyepoint Pharmaceuticals Inc (EYPT)

Eyepoint Pharmaceuticals Inc (EYPT)
4.50 x 1 5.10 x 1
Post-market by (Cboe BZX)
4.61 -0.38 (-7.62%) 04/04/25 [NASDAQ]
4.50 x 1 5.10 x 1
Post-market 4.61 unch (unch) 17:42 ET
News & Headlines for Fri, Apr 4th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
EyePoint to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference GlobeNewswire - Thu Mar 27, 6:00AM CDT

EYPT : 4.61 (-7.62%)
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire - Mon Mar 17, 6:00AM CDT

EYPT : 4.61 (-7.62%)
EyePoint Pharmaceuticals: Q4 Earnings Snapshot AP - Wed Mar 5, 6:34AM CST

EyePoint Pharmaceuticals: Q4 Earnings Snapshot

EYPT : 4.61 (-7.62%)
EyePoint Reports Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Developments GlobeNewswire - Wed Mar 5, 6:00AM CST

EYPT : 4.61 (-7.62%)
EyePoint Announces Participation at Upcoming Investor Conferences GlobeNewswire - Tue Mar 4, 6:00AM CST

EYPT : 4.61 (-7.62%)
EyePoint to Report Fourth Quarter and Full-Year 2024 Financial Results on March 5, 2025 GlobeNewswire - Wed Feb 26, 6:00AM CST

EYPT : 4.61 (-7.62%)
EyePoint to Present Corporate Update at TD Cowen 45th Annual Health Care Conference GlobeNewswire - Tue Feb 25, 6:00AM CST

EYPT : 4.61 (-7.62%)
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire - Mon Feb 17, 6:00AM CST

EYPT : 4.61 (-7.62%)
EyePoint Announces Positive Six-Month Results for the Phase 2 VERONA Clinical Trial of DURAVYU™ for Diabetic Macular Edema Meeting Primary and Secondary Endpoints GlobeNewswire - Wed Feb 5, 6:00AM CST

EYPT : 4.61 (-7.62%)
EyePoint to Present at Guggenheim SMID Cap Biotech Conference GlobeNewswire - Thu Jan 30, 6:00AM CST

EYPT : 4.61 (-7.62%)

Barchart Exclusives

Should You Buy the Dip in Apple Stock in April 2025? Barchart - Sat Apr 5, 6:00AM CDT
Here is what you should do as Apple falls 22% from its 52-week high. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades
Wed, Apr 09, 2025 5:00 PM UTC
Reserve Your Spot